Drug & supplement interaction

Expressive Therapies + Ruxolitinib

Ruxolitinib brand names: Jakafi, Opzelura.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Expressive Therapies and Ruxolitinib in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone interested in this? Share
Interaction report

Expressive Therapies and Ruxolitinib

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Ruxolitinib and Expressive Therapies in our sources. This does not guarantee that the combination is completely free of risk — research on Expressive Therapies alongside specific medications may be limited.

Worth understanding: our licensed dataset holds no drug-interaction record for Expressive Therapies at all — not against Ruxolitinib, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.

Expressive Therapies is a treatment rather than something you take. Tell whoever provides it which medicines you use, and ask your prescriber whether it is appropriate for your health and treatment. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Expressive Therapies safety at a glance

Expressive Therapi... overall Generally safe Generally considered safe and low-risk when guided by a trained therapist.
Pregnancy Generally safe Non-drug creative therapies are generally safe during pregnancy.
Breastfeeding Generally safe Non-drug creative therapies are generally safe while breastfeeding.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Ruxolitinib and Expressive Therapies? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
What to actually watch for

What Ruxolitinib’s Own FDA Label Lists

This is not an interaction — none of it involves Expressive Therapies. These are the most notable effects listed in the ADVERSE REACTIONS section of Ruxolitinib’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you have Expressive Therapies and take the medicine. 10 of them are worth acting on rather than waiting out — marked below.

  • Unsteadiness Worth acting on
  • Low blood sugar Worth acting on
  • Blood clots Worth acting on
  • Anemia Worth acting on mentioned in 8.6% of FDA reports for Ruxolitinib
  • A low platelet count Worth acting on mentioned in 3.9% of FDA reports for Ruxolitinib
  • A severe skin reaction Worth acting on
  • Raised blood pressure Worth acting on
  • Shortness of breath Worth acting on
  • A low white blood cell count Worth acting on
  • Bleeding or bruising Worth acting on

Showing the 10 most notable of 24 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the ADVERSE REACTIONS section of the FDA label for Ruxolitinib. Read the label on DailyMed › Where a percentage is shown, it is the share of 69,262 voluntary FDA FAERS reports for Ruxolitinib that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Expressive Therapies’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no Expressive Therapies side to compare — that is a limit of the record, not a statement that Expressive Therapies has no side effects.

Everything else you take

See Every Supplement That Interacts With Ruxolitinib

This page covers Expressive Therapies only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Ruxolitinib page lists 141 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), Grapefruit (major), St. John's Wort (major), Acacia Rigidula (moderate) and Adrafinil (moderate).

By severity: 3 major · 96 moderate · 42 minor.

From our pharmacist’s overview on the Ruxolitinib page

“Ruxolitinib (Jakafi for myelofibrosis and other blood cancers, Opzelura as a skin cream) is cleared by one liver enzyme, CYP3A4, and that single fact explains nearly all 141 supplements here, which is why this list deserves real caution. Three entries are rated major.”

Reviewed by 2 · Jul 18, 2026

Open the Ruxolitinib interaction page

How much people look this up

Where Expressive Therapies and Ruxolitinib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Expressive Therapies
Steady interest

#1,388 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Ruxolitinib
Top 25%

#338 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions. Expressive Therapies is not yet covered by that licensed database, so its write-up cites publicly available medical sources directly (see the references below).
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Expressive Therapies reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Expressive Therapies and Ruxolitinib records this page draws on were last updated June 20, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Treatment approach

About Expressive Therapies

What is Expressive Therapies?

  • Anxiety and stress
  • Depression and low mood
  • Coping with trauma or grief
  • Emotional expression and self-awareness
  • Support during serious illness or rehabilitation

Expressive therapies are mind-body treatments that use creative activities like art, music, dance, drama, or writing to help people process emotions and improve mental well-being. They are not a supplement, herb, or medicine you take. They are generally low-risk and are usually used alongside, not instead of, standard medical or mental health care.

Not applicable — this is a mind-body therapy, not a plant or supplement · Art therapy, music therapy, dance/movement therapy, drama therapy, writing/poetry therapy

An interaction check asks whether these two react with each other — it does not ask whether Expressive Therapies is a good idea for someone in your situation. Here is what our Expressive Therapies record says about it on its own.

Expressive Therapies: dosing

There is no standard "dose" for expressive therapies because they are activities, not products. How often and how long sessions last can vary widely depending on the type of therapy, the program, and your goals.Sessions are often offered weekly, in either one-on-one or group settings, and may run for several weeks or longer. Look for therapists who are licensed or certified in their specific field, such as a board-certified music therapist or registered art therapist.

From our Expressive Therapies monograph — the full record covers uses, side effects and every documented interaction.

Read the full Expressive Therapies monograph & all interactions
Medication

About Ruxolitinib

What Is Ruxolitinib Used For?

Brand names: Jakafi, Opzelura

Ruxolitinib is approved to treat several serious blood and immune conditions in adults, and some in patients as young as 12. It is used for myelofibrosis (a bone marrow disorder that disrupts normal blood cell production), polycythemia vera (a condition where the bone marrow makes too many red blood cells), and two forms of graft-versus-host disease (GVHD) — a complication that can occur after a stem cell transplant.

For polycythemia vera, it is specifically for patients who have not responded well to, or cannot tolerate, a medication called hydroxyurea. For chronic GVHD, it is used after at least one or two other treatments have failed.

Most-Reported Side Effects for Ruxolitinib

From FAERS, the FDA’s public side-effect reporting system (71,241 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Fatigue 6,114 reports
Anemia 3,094 reports
Haemoglobin decreased 2,961 reports
Platelet count decreased 2,700 reports
Diarrhea 2,683 reports
See full Ruxolitinib drug information
Keep checking

Other Drugs & Expressive Therapies

Browse every other medication we’ve checked against Expressive Therapies — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
0Moderate
0Minor
2,829No known interaction
No interaction 2,829 drugs checked — show the list
Evidence & sources

Expressive Therapies References

The 1 sources that drive our Expressive Therapies monograph — publicly available pages from reputable medical and government organizations. Every link was verified to work before publishing. Expressive Therapies is not covered by the licensed Natural Medicines interaction database, so its page cites these public sources directly.

  1. Complementary, Alternative, or Integrative Health: What's In a Name? — NIH NCCIH Source

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Having Expressive Therapies While Taking Ruxolitinib: Common Questions

Is it safe to have Expressive Therapies while taking Ruxolitinib?
We do not list a known interaction between Expressive Therapies and Ruxolitinib. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Does Ruxolitinib interact with any supplements?
Yes. Ruxolitinib has documented interactions with 141 supplements in our database — Expressive Therapies is not one of them. The Ruxolitinib interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Ruxolitinib and Expressive Therapies?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.